Zusammenfassung
Entsprechend den derzeitigen Therapieempfehlungen konzentrieren sich 69% der Antiepileptikaverordnungen auf die drei Standardtherapeutika Carbamazepin, Valproinsäure und Phenytoin.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, et al. for the Gabapentin Diabetic Neuropathy Study Group (1998): Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 280:1831–1836.
Ben-Menachem E, Scheepers B, Stodieck S (2003): Epilepsy: from consensus to daily practice. Acta Neurol Scand 108(Suppl 180): 5–15.
Beydoun A (1997): Monotherapy trials of new antiepileptic drugs. Epilepsia 38(Suppl 9):S21–S31.
Beydoun A (1999): Monotherapy trials with gabapentin for partial epilepsy. Epilepsia 40(Suppl 6): S13–S16.
Charatan F (2002): Doctor sues company over unethical marketing. Brit Med J 324: 1234.
Dooley M, Plosker GL (2000): Levetiracetam. A review of its adjunctive use in the management of partial onset seizures. Drugs 60: 871–893.
Feely M (1999): Drug treatment of epilepsy. Brit Med J 318:106–109.
Goa KL, Ross SR, Chrisp P (1993): Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy. Drugs 46:152–176.
Groß-Selbeck G (1995): Treatment of „benign“ partial epilepsies of childhood, including atypical forms. Neuropediatrics 26:45–50.
Heaney DC, Shorvon SD, Sander JW (1998): An economic appraisal of carbamazepine, lamotrigine, phenytoin and valproate as initial treatment in adults with newly diagnosed epilepsy. Epilepsia 39(Suppl 3): S19–S25.
Hufnagel A, Noachtar S (1998): Epilepsien und ihre medikamentöse Behandlung. In: Brandt T, Dichgans J, Diener HC (Hrsg): Therapie und Verlauf neurologischer Erkrankungen. 3. Aufl., Kohlhammer, Stuttgart, Berlin, Köln, S. 179–203.
Jette NJ, Marson AG, Kadir ZA, Hutton JL (2000): Topiramate for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2: CD001417.
McKee PJ, Blacklaw J, Forrest G, Gillham RA, Walker SM, Connelly D, Brodie MJ (1994): A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients. Br J Clin Pharmacol 37: 27–32.
Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA (1999): Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 159:1931–1937.
Stefan H, Halász P, Gil-Nagel A, Shorvon S, Bauer G, Ben-Menachem E et al. (2001): Recent advances in the diagnosis and treatment of epilepsy. Eur J Neurol 8: 519–539.
Visintini D, Calzetti S, Mancia D (1981): Il barbexaclone nel trattamento delle epilessie. Riv Patol Nerv Ment 102:29–37.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schwabe, U. (2004). Antiepileptika. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2004. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18513-7_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-18513-7_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-21359-8
Online ISBN: 978-3-642-18513-7
eBook Packages: Springer Book Archive